Following a string of high-profile FDA warnings and product recalls, a new platform is pushing for mandatory third-party testing in the functional mushroom space.
When the FDA issued a nationwide recall for Diamond Shruumz-brand chocolate bars and gummies in the summer of 2024, the fallout rippled across the entire mushroom supplement industry. The recall, prompted by reports of severe illnesses and hospitalizations linked to undisclosed compounds, highlighted a vulnerability that industry insiders had warned about for years: the functional mushroom market was growing faster than its regulatory guardrails.
The Diamond Shruumz incident was not isolated. In late 2025, the FDA issued warning letters to several companies, including Blue Forest Farms, over adulterated Amanita muscaria products. For consumers navigating the supplement aisle, the message was clear: the label on the bottle doesn't always match what's inside.
"The recalls were a wake-up call, but they were also entirely predictable," says Justin Hartfield, founder of ShrooMap and co-founder of Weedmaps, the cannabis industry's largest marketplace. "When you have a category growing at double digits year over year, with minimal pre-market FDA oversight, you're going to attract bad actors. The challenge now isn't just removing the bad products—it's proving to consumers that the good products are actually safe."
The Testing Gap
Unlike pharmaceuticals, dietary supplements in the United States do not require FDA approval before hitting the market. The burden of ensuring safety and accurate labeling falls largely on the manufacturer. In the functional mushroom space, this has created a bifurcated market: premium brands that invest heavily in third-party testing, and discount brands that rely on "label claims" without independent verification.
The risks go beyond undisclosed psychoactive compounds. Mushrooms are bioaccumulators, meaning they readily absorb heavy metals and toxins from their growing environment. A 2024 study published in Scientific Reports noted that mushrooms can accumulate dangerous levels of arsenic, cadmium, mercury, and lead if grown in contaminated soil or substrate.
"If a company isn't testing for heavy metals, you shouldn't be consuming their product," Hartfield advises. "It's that simple. But historically, consumers haven't had an easy way to check those lab results before making a purchase."
A New Standard for Transparency
ShrooMap, which Hartfield describes as "the Weedmaps of mushrooms," was built specifically to address this transparency gap. The platform independently verifies Certificates of Analysis (COAs) for the 40-plus brands it reviews, checking not just for heavy metals and microbial contaminants, but also for beta-glucan content—the primary bioactive compound in functional mushrooms.
Every product review on the platform is checked by Dr. Irvine Russell, a board-certified physician affiliated with UC Irvine's School of Medicine. Products receive a standardized rating across five categories: value, ingredients, taste, transparency, and
customer support. Brands that fail to provide current, verifiable COAs are flagged, giving consumers immediate visibility into a company's testing practices.
"If a company won't show you their testing, that tells you something," says Hartfield. "We've tested products that list 'Lion's Mane extract' on the label but are mostly mycelium grown on grain—essentially rice filler with trace amounts of the actual mushroom. Without third-party verification, the consumer is flying blind."
Beyond the Bottle
The push for transparency extends to the retail level. ShrooMap has mapped over 748 retail locations that carry mushroom products across the U.S. and Europe, from specialty health stores to headshops. The platform tracks which specific brands each store carries, allowing consumers to find verified, highly-rated products locally.
In markets where psilocybin products are legal, the platform maintains a separate directory of over 100 smartshops across the Netherlands, Canada, Jamaica, and other jurisdictions, applying the same rigorous standards for accurate information.
"We're not advocates for any particular substance," Hartfield clarifies. "We're advocates for accurate information. Whether someone is buying Lion's Mane for cognitive support or looking into psilocybin microdosing where it's legal, they deserve to know exactly what they're getting."
As the functional mushroom category continues its rapid growth trajectory, the industry faces a critical inflection point. The recent recalls have demonstrated the cost of operating without transparency. Platforms like ShrooMap are betting that the future of the industry belongs to the brands—and the retailers—willing to prove what's in the bottle.
ⓒ 2026 TECHTIMES.com All rights reserved. Do not reproduce without permission.
